News
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the ...
Novo Nordisk (NYSE: NVO) and Cava Group (NYSE: CAVA) are excellent choices. Novo Nordisk's shares have significantly lagged ...
Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that the most ...
As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...
Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...
Evan Reynolds, one of the lead researchers, says this is an important discovery. It shows that type 2 diabetes may begin to change the brain quietly, without causing clear symptoms right away. That ...
LONG ISLAND - Michael, a 48-year-old from Suffolk County, is suing Ozempic's manufacturer for loss of vision. Michael, who opted out of sharing his surname, says that the loss of sight began after his ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
Scientists discover unique insulin responses in each person, opening new paths for early diabetes detection and treatment.
Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular events. Despite clinicians recommending that many patients with diabetes take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results